Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg And 5mg Tablets, El(26)a/17

Summary Sandoz Limited is recalling certain batches of Apixaban 2.5mg and 5mg tablets in the UK because the Patient Information Leaflet included with the medication contains outdated information. The tablets themselves are not affected, only the printed instructions provided to patients. This recall applies to specified batches distributed in the United Kingdom.

Recalling firm
Sandoz Limited
Reason
Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.
Classification
Class III
Category
drug recall
Country
United Kingdom
Agency
UK Medicines and Healthcare products Regulatory Agency
Recall date
2026-03-26
Status
Ongoing
Distribution
United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/3fc8086b-2ef4-4800-a547-379b8ec024b5